Quick Answer
Eledon Pharmaceuticals, Inc. reported Operating Income of -$43.00 million for fiscal year 2023.
Eledon Pharmaceuticals, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2023 | -$43.00M | +51.4% |
| 2022 | -$88.43M | -139.9% |
| 2021 | -$36.87M | -99.7% |
| 2020 | -$18.46M | -15.0% |
| 2019 | -$16.05M | -14.2% |
| 2018 | -$14.06M | -7.2% |
| 2017 | -$13.12M | -155.9% |
| 2016 | -$5.13M | +88.7% |
| 2015 | -$45.26M | -92.9% |
| 2014 | -$23.46M | -49.0% |
| 2013 | -$15.75M | -63.2% |
| 2012 | -$9.65M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$19.07M | +7.0% | +22.9% |
| June 30, 2025 | -$24.73M | -70.5% | -37.7% |
| March 31, 2025 | -$17.96M | -65.3% | +12.4% |
| September 30, 2024 | -$20.51M | -83.2% | -41.4% |
| June 30, 2024 | -$14.50M | -40.1% | -33.4% |
| March 31, 2024 | -$10.87M | +2.2% | +2.9% |
| September 30, 2023 | -$11.20M | -5.7% | -8.2% |
| June 30, 2023 | -$10.35M | -11.5% | +6.8% |
- Eledon Pharmaceuticals, Inc. showed an increase of +51.4% in Operating Income compared to the prior fiscal year.
- Over the 2012–2023 period, Eledon Pharmaceuticals, Inc.’s operating income has declined by 345.6% (from -$9.65 million to -$43.00 million).
- The most recent figure is from Eledon Pharmaceuticals, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 28, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: